Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Leonard

Showing results (601-610 of 686) with videos related to

Pageof 69
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2006
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphomaRichard I Fisher, Steven H Bernstein, Brad S Kahl, et al.
Journal of the National Cancer Institute|January 2, 2017
Hodgkin Lymphoma: Current Status and Clinical Trial RecommendationsCatherine S Diefenbach, Joseph M Connors, Jonathan W Friedberg, et al.
Hemasphere|November 15, 2019
Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic LeukemiaSteven E Coutre, Ian W Flinn, Sven de Vos, et al.
The Journal of Experimental Medicine|September 21, 2005
Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitisSuzana Marusic, Michael W Leach, Jeffrey W Pelker, et al.
Blood|October 5, 2016
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103Chaitra S Ujjani, Sin-Ho Jung, Brandelyn Pitcher, et al.
Nature Medicine|June 22, 2010
Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse modelsThomas A Natoli, Laurie A Smith, Kelly A Rogers, et al.
Stem Cell Reports|August 6, 2019
A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte PathologyMatthew J Birket, Sophie Raibaud, Miriam Lettieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphomaKhuda D Khan, Christos Emmanouilides, Don M Benson, et al.
Archives of Pathology & Laboratory Medicine|November 11, 2020
Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American PathologistsSteven H Kroft, Cordelia E Sever, Adam Bagg, et al.
American Journal of Clinical Pathology|November 21, 2020
Laboratory Workup of Lymphoma in AdultsSteven H Kroft, Cordelia E Sever, Adam Bagg, et al.
Pageof 69

Showing results (601-610 of 686) with videos related to

Sort By:
Pageof 69
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2006
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphomaRichard I Fisher, Steven H Bernstein, Brad S Kahl, et al.
Journal of the National Cancer Institute|January 2, 2017
Hodgkin Lymphoma: Current Status and Clinical Trial RecommendationsCatherine S Diefenbach, Joseph M Connors, Jonathan W Friedberg, et al.
Hemasphere|November 15, 2019
Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic LeukemiaSteven E Coutre, Ian W Flinn, Sven de Vos, et al.
The Journal of Experimental Medicine|September 21, 2005
Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitisSuzana Marusic, Michael W Leach, Jeffrey W Pelker, et al.
Blood|October 5, 2016
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103Chaitra S Ujjani, Sin-Ho Jung, Brandelyn Pitcher, et al.
Nature Medicine|June 22, 2010
Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse modelsThomas A Natoli, Laurie A Smith, Kelly A Rogers, et al.
Stem Cell Reports|August 6, 2019
A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte PathologyMatthew J Birket, Sophie Raibaud, Miriam Lettieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphomaKhuda D Khan, Christos Emmanouilides, Don M Benson, et al.
Archives of Pathology & Laboratory Medicine|November 11, 2020
Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American PathologistsSteven H Kroft, Cordelia E Sever, Adam Bagg, et al.
American Journal of Clinical Pathology|November 21, 2020
Laboratory Workup of Lymphoma in AdultsSteven H Kroft, Cordelia E Sever, Adam Bagg, et al.
Pageof 69